Aclaris Therapeutics, Inc

(NASDAQ:ACRS)

Latest On Aclaris Therapeutics, Inc (ACRS):

Date/Time Type Description Signal Details
2021-03-16 16:01 ESTNewsAclaris Therapeutics (ACRS) Presents At H.C. Wainwright Global Life Sciences Virtual Conference - SlideshowN/A
2021-03-15 16:01 ESTNewsAclaris completes enrollment of mid-stage trial for atopic dermatitisN/A
2021-03-05 15:01 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $26.67.Buy
2021-03-03 02:01 ESTNewsAclaris Therapeutics: A Potential Big Pharma Deal May Be In The HorizonN/A
2021-02-26 15:01 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 03:01 ESTEarnings EstimateAn EPS average of -$1.04 is estimated for the 2022 year.Sell
2021-02-26 03:01 ESTEarnings EstimateAn EPS average of -$0.28 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-25 18:35 ESTNewsAclaris Therapeutics EPS misses by $0.04, beats on revenueN/A
2021-02-22 16:16 ESTNewsAclaris Therapeutics stock spikes after speculation of potential sale (update)N/A
2021-02-02 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $20 to $25.Buy
2021-01-21 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $14 to $20.Buy
2021-01-20 13:32 ESTNewsAclaris shares rise 10% after pricing equity offeringN/A
2021-01-20 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.83 to $14.Neutral
2021-01-19 23:31 ESTNewsAclaris Therapeutics readies proposed public offeringN/A
2021-01-19 08:31 ESTNewsAclaris stock surges on positive data from mid-stage rheumatoid arthritis ATI-450 trialN/A
2021-01-16 11:00 ESTNewsStocks To Watch: Earnings Day For Netflix, Intel And Procter & GambleN/A
2020-12-22 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.5 to $5.83.Neutral
2020-12-17 11:01 ESTAnalyst RatingThe Analyst Target Price has increased from $4.83 to $5.5.Buy
2020-11-25 11:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 11:02 ESTEarnings EstimateAn EPS average of -$0.37 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-08 23:01 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:01 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 11:02 ESTAnalyst RatingThe Analyst Target Price has increased from $4.5 to $4.83.Buy
2020-11-04 21:36 ESTNewsAclaris Therapeutics EPS beats by $0.05, misses on revenueN/A
2020-11-01 16:49 ESTFinancialsCompany financials have been released.Neutral
2020-10-20 13:48 ESTNewsDosing underway for Aclaris's ATI-1777 in mid-stage atopic dermatitis studyN/A
2020-09-26 04:02 ESTFinancialsCompany financials have been released.Neutral
2020-09-24 16:02 ESTFinancialsCompany financials have been released.Neutral
2020-09-03 17:00 ESTInsider TradeNeal Walker has directly acquired 83,092 shares and currently holds 1,170,023 shares.Buy
2020-08-13 04:01 ESTFinancialsCompany financials have been released.Neutral
2020-08-09 00:01 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 11:17 ESTNewsAclaris Therapeutics EPS beats by $0.07, beats on revenueN/A
2020-07-23 16:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-15 18:01 ESTInsider TradeDavid N. Gordon has directly acquired 6,000 shares and currently holds 88,895 shares.Buy
2020-07-08 03:31 ESTNewsAclaris gains ~8% after filing IND for ATI-1777 in dermatitisN/A
2020-06-18 04:35 ESTNewsAclaris up big on study of lead drug in COVID-19N/A
2020-06-10 23:33 ESTNewsStates go after generic drugmakers for alleged price-fixingN/A
2020-06-08 18:30 ESTInsider TradeANDREW N SCHIFF has directly acquired 7,333 shares and currently holds 16,209 shares.Buy
2020-06-08 18:30 ESTInsider TradeAndrew Kenneth William Powell has directly acquired 7,333 shares and currently holds 16,709 shares.Buy
2020-06-08 18:30 ESTInsider TradeWilliam D. Humphries has directly acquired 7,333 shares and currently holds 16,209 shares.Buy
2020-06-08 18:30 ESTInsider TradeAnand Mehra has directly acquired 7,333 shares and currently holds 16,209 shares.Buy
2020-06-08 18:30 ESTInsider TradeChristopher P. Molineaux has directly acquired 7,333 shares and currently holds 23,891 shares.Buy
2020-06-08 18:30 ESTInsider TradeBryan M. Reasons has directly acquired 7,333 shares and currently holds 16,209 shares.Buy
2020-06-03 17:00 ESTInsider TradeKamil Ali-Jackson has directly acquired 33,188 shares and currently holds 132,387 shares.Buy
2020-06-03 17:00 ESTInsider TradeDavid N. Gordon has directly acquired 87,500 shares and currently holds 106,940 shares.Buy
2020-06-03 17:00 ESTInsider TradeFrank Ruffo has directly acquired 33,188 shares and currently holds 221,143 shares.Buy
2020-06-03 17:00 ESTInsider TradeNeal Walker has directly acquired 73,014 shares and currently holds 1,107,907 shares.Buy
2020-06-02 08:01 ESTEarnings EstimateAn EPS average of -$0.36 is estimated for the quarter ending on September 30, 2020.Buy
2020-05-15 20:01 ESTFinancialsCompany financials have been released.Neutral
2020-05-10 16:23 ESTFinancialsCompany financials have been released.Neutral

About Aclaris Therapeutics, Inc (ACRS):

Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational oral, novel, small molecule selective MK2 inhibitor compound that is in phase 2 clinical trial for the treatment of moderate to severe rheumatoid arthritis, COVID-19, and additional immuno-inflammatory diseases; ATI-1777, an investigational topical soft JAK 1/3 inhibitor compound, which is in phase 2a clinical trial to treat moderate to severe atopic dermatitis; and ATI-2138, an investigational oral ITK/TXK/JAK3 inhibitor compound for the treatment for psoriasis and/or inflammatory bowel disease, as well as A-101 45% topical solution to treat common warts. It also provides contract research services. Aclaris Therapeutics, Inc. has a license and collaboration agreement with Rigel Pharmaceuticals, Inc. for the development and commercialization of JAK inhibitors. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

See Advanced Chart

General

  • Name Aclaris Therapeutics, Inc
  • Symbol ACRS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 57
  • Fiscal Year EndDecember
  • IPO Date2015-10-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.aclaristx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 156.98
  • Price/Book (Most Recent Quarter) 32.91
  • Enterprise Value Revenue 184.55
  • Enterprise Value EBITDA 0.05
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$1.38
  • Operating Margin -749%
  • Return on Assets -36%
  • Return on Equity -95%
  • Revenue 6.48 million
  • Earnings Per Share -$4.17
  • Revenue Per Share $0.15
  • Gross Profit -27989000
  • Quarterly Earnings Growth 44.3%
View More

Highlights

  • Market Capitalization 1.29 billion
  • EBITDA -134348000
  • PE Ratio -27.09
  • PEG Ratio -0.13
  • Analyst Target Price $26.67
  • Book Value Per Share $0.84
View More

Share Statistics

  • Shares Outstanding 51.8 million
  • Shares Float 35.44 million
  • % Held by Insiders 964%
  • % Held by Institutions 66.13%
  • Shares Short 758989
  • Shares Short Prior Month 1.45 million
  • Short Ratio 0.72
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.66
  • 52 Week High $26.5
  • 52 Week Low $0.85
  • 50 Day Moving Average 22.3
  • 200 Day Moving Average 9.26
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aclaris Therapeutics, Inc (ACRS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aclaris Therapeutics, Inc (ACRS) Earnings Estimates:

An earnings estimate is an analyst's estimate for a company's future quarterly or annual earnings per share (EPS). Future earnings estimates are arguably the most important data when attempting to value a firm.

ACRS's EPS estimate for the current year is -$1.05
Date Number of Analysts Average Estimate Low Estimate High Estimate
2021-06-301-$0.28-$0.28-$0.28

Aclaris Therapeutics, Inc (ACRS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

ACRS's next estimated earnings release date is May 7, 2021.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$1.58 million-$0.30-$0.26-15.38%
2020-09-302020-11-04$1.45 million-$0.25-$0.3118.03%
2020-06-302020-08-07$N/A-$0.28-$0.3621.13%
2020-03-312020-05-07$1.41 million-$0.37-$0.381.33%
2019-12-312020-02-25$1.1 million-$0.45-$0.39-16.37%
2019-09-302019-11-07$983000-$1.34-$0.69-94.2%
2019-06-302019-08-08$5.87 million-$1.21-$0.75-62.2%
2019-03-312019-05-08$5.04 million-$0.91-$0.80-13.4%
2018-12-312019-03-18$3.67 million-$0.99-$0.98-0.68%
2018-09-302018-11-06$1.63 million-$1.06-$1.3320.1%
2018-06-302018-08-03$3.68 million-$1.01-$1.097.62%
2018-03-312018-05-08$1.12 million-$0.98-$1.002.32%
2017-12-312018-03-12$999000-$0.74-$0.8815.91%
2017-09-302017-11-07$684000-$0.63-$0.8727.59%
2017-06-302017-08-08$N/A-$0.56-$0.7323.29%
2017-03-312017-05-09$N/A-$0.48-$0.5918.64%
2016-12-312017-03-15$N/A-$0.49-$0.6422.83%
2016-09-302016-11-03$N/A-$0.50-$0.6725.65%
2016-06-302016-08-11$N/A-$0.62-$0.654.13%
2016-03-312016-05-11$N/A-$0.65-$0.50-30%
2015-12-312016-03-23$N/A-$0.28-$0.4537.78%
2015-09-302015-10-13$N/A-$5.11-$2.84-79.93%

Aclaris Therapeutics, Inc (ACRS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aclaris Therapeutics, Inc (ACRS) Chart:

Aclaris Therapeutics, Inc (ACRS) News:

Below you will find a list of latest news for Aclaris Therapeutics, Inc (ACRS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aclaris Therapeutics, Inc (ACRS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2021-05-212.519.9CALL4 160TRUE-1.6-0.07
2021-05-21524CALL2 48765.46TRUE5.20.28
2021-05-217.520CALL1 16562.81TRUE9.50.9
2021-05-211016CALL1 141444.08TRUE-4.15-0.21
2021-05-2112.517.7CALL5 101360.06TRUE7.20.69
2021-05-211512.5CALL5 29147.09TRUE00
2021-05-2117.59.3CALL3 697.71TRUE0.620.07
2021-05-21208.4CALL10 51141.01TRUE-0.1-0.01
2021-05-2122.55.6CALL2 12898.9TRUE-2.8-0.33
2021-05-21254.4CALL60 480107TRUE1.10.33
2021-05-21302.15CALL79 87894.35FALSE0.310.17
2021-05-21350.9CALL65 43499.3FALSE0.20.29
2021-05-21400.4CALL1 2102.39FALSE-0.72-0.64
2021-05-212.50.05PUT70 2090FALSE00
2021-05-2150.05PUT1 1420FALSE00
2021-05-217.50.1PUT1 70235.52FALSE0.010.11
2021-05-21100.25PUT15 810FALSE-0.26-0.51
2021-05-2112.50.35PUT325 6640FALSE0.050.17
2021-05-21150.9PUT1 9170.63FALSE-1.3-0.59
2021-05-2117.50.3PUT4 26112.53FALSE-0.1-0.25
2021-05-21200.38PUT3 5092.89FALSE-0.32-0.46
2021-05-2122.51PUT1 1996.67FALSE-0.5-0.33
2021-05-21251.75PUT38 27391.07FALSE-0.77-0.31
2021-05-21304.7PUT10 1295.18TRUE-0.7-0.13
2021-05-21350PUT 92.78TRUE00
2021-05-21400PUT 97.44TRUE00
2021-06-18150CALL 124.37TRUE00
2021-06-1817.50CALL 124.95TRUE00
2021-06-18208.9CALL4 119.07TRUE8.90
2021-06-1822.50CALL 91.06TRUE00
2021-06-18255.05CALL7 293.36TRUE-1.45-0.22
2021-06-18302.99CALL68 293.93FALSE0.490.2
2021-06-18351.6CALL4 291.06FALSE-1.4-0.47
2021-06-18400.75CALL2 86.67FALSE0.750
2021-06-18150.35PUT100 100115.7FALSE0.350
2021-06-1817.50.58PUT1 1199.91FALSE-0.22-0.28
2021-06-18201PUT1 1093.91FALSE-0.44-0.31
2021-06-1822.51.93PUT1 97.83FALSE1.930
2021-06-18250PUT 97.77FALSE00
2021-06-18300PUT 93.01TRUE00
2021-06-18350PUT 94.99TRUE00
2021-06-18400PUT 91.92TRUE00
2021-08-202.526.75CALL5 2285.78TRUE9.250.53
2021-08-20524.3CALL5 12236.91TRUE2.90.14
2021-08-207.515.8CALL1 151139.54TRUE0.80.05
2021-08-201013.3CALL10 130119.14TRUE00
2021-08-2012.510.3CALL3 98112.63TRUE-2-0.16
2021-08-201510.8CALL1 586.06TRUE0.50.05
2021-08-2017.512CALL3 14100.95TRUE2.260.23
2021-08-20208.11CALL2 2694TRUE-2.95-0.27
2021-08-2022.56.9CALL64 7391.76TRUE10.17
2021-08-20256.3CALL1 2186.4TRUE0.310.05
2021-08-20304.81CALL2 3294.18FALSE1.210.34
2021-08-20353.4CALL5 6088.34FALSE-0.7-0.17
2021-08-20400CALL 90.06FALSE00
2021-08-202.50.05PUT1 3230FALSE00
2021-08-2050.35PUT1 220FALSE0.36
2021-08-207.50.1PUT1 1780FALSE-0.5-0.83
2021-08-20100.25PUT6 1030FALSE0.050.25
2021-08-2012.50.5PUT1 27103.2FALSE-0.75-0.6
2021-08-20152.7PUT1 695.72FALSE-0.4-0.13
2021-08-2017.51.3PUT8 1895.37FALSE-0.05-0.04
2021-08-20204.27PUT1 2596.32FALSE-0.38-0.08
2021-08-2022.53.19PUT3 1094.23FALSE-0.21-0.06
2021-08-20255.4PUT1 60192.57FALSE1.190.28
2021-08-20307.5PUT1 191.66TRUE-3.02-0.29
2021-08-20350PUT 92.09TRUE00
2021-08-20400PUT 92.36TRUE00
2021-11-1912.50CALL 74.42TRUE00
2021-11-19150CALL 105.02TRUE00
2021-11-1917.50CALL 90.39TRUE00
2021-11-192012.61CALL1 189.48TRUE12.610
2021-11-1922.50CALL 89.8TRUE00
2021-11-19257.2CALL1 187.88TRUE7.20
2021-11-19305.79CALL1 1086.89FALSE-0.01-0
2021-11-19354.2CALL5 1686.61FALSE-1.04-0.2
2021-11-19404.6CALL1 187.1FALSE4.60
2021-11-1912.51.1PUT2 295.04FALSE1.10
2021-11-19152PUT3 399.81FALSE20
2021-11-1917.50PUT 92.91FALSE00
2021-11-19200PUT 92.44FALSE00
2021-11-1922.50PUT 92.07FALSE00
2021-11-19257.5PUT45 10391.32FALSE00
2021-11-19309.1PUT2 89.43TRUE9.10
2021-11-19350PUT 89.72TRUE00
2021-11-19400PUT 88.44TRUE00

Latest ACRS Asks & Bids:

Date Shares Price Type
Apr 22, 2021 3:19 PM EST100$26.79Bid
Apr 22, 2021 10:17 AM EST100$30.1Ask
Apr 22, 2021 12:37 PM EST91$27.44Ask

Latest ACRS Trades:

Date Shares Price
Apr 22, 2021 3:14 PM EST100$26.93
Apr 22, 2021 3:16 PM EST100$26.86
Apr 22, 2021 3:16 PM EST100$26.875
Apr 22, 2021 3:16 PM EST100$26.875
Apr 22, 2021 3:18 PM EST9$26.875

Aclaris Therapeutics, Inc (ACRS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090266420002531/0000902664-20-002531-index.htm
2020-03-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1557746/000000000020002443/0000000000-20-002443-index.htm
2019-01-25SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000003877719000005/0000038777-19-000005-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000003877720000013/0000038777-20-000013-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000021545719003192/0000215457-19-003192-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000031506619000849/0000315066-19-000849-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000031506620000819/0000315066-20-000819-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000083423720004757/0000834237-20-004757-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000083423720009989/0000834237-20-009989-index.htm
2019-08-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542119000589/0000895421-19-000589-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542120000139/0000895421-20-000139-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000089542120000278/0000895421-20-000278-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090266420002531/0000902664-20-002531-index.htm
2019-10-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445419000691/0000904454-19-000691-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445420000171/0000904454-20-000171-index.htm
2020-07-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090445420000503/0000904454-20-000503-index.htm
2019-07-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090514819000691/0000905148-19-000691-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000090514820000306/0000905148-20-000306-index.htm
2019-01-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000091957419000663/0000919574-19-000663-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000091957420001125/0000919574-20-001125-index.htm
2019-10-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519002554/0000921895-19-002554-index.htm
2019-11-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519002853/0000921895-19-002853-index.htm
2019-12-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000092189519003037/0000921895-19-003037-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000093583620000140/0000935836-20-000140-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000103738920000090/0001037389-20-000090-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465919049176/0001104659-19-049176-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920021847/0001104659-20-021847-index.htm
2020-03-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920030172/0001104659-20-030172-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465920033094/0001104659-20-033094-index.htm
2020-03-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1557746/000110465920033140/0001104659-20-033140-index.htm
2020-04-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1557746/000110465920050082/0001104659-20-050082-index.htm
2020-04-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1557746/000110465920053341/0001104659-20-053341-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1557746/000110465920094778/0001104659-20-094778-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000110465920094781/0001104659-20-094781-index.htm
2020-10-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000110465920118249/0001104659-20-118249-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000114420419008093/0001144204-19-008093-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266119001597/0001172661-19-001597-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266120000734/0001172661-20-000734-index.htm
2020-10-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000117266120002035/0001172661-20-002035-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380518001435/0001193805-18-001435-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380518001441/0001193805-18-001441-index.htm
2019-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000014/0001193805-19-000014-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000067/0001193805-19-000067-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000181/0001193805-19-000181-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm
2019-07-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380519000689/0001193805-19-000689-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1557746/000119380520000193/0001193805-20-000193-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063368/0001209191-18-063368-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063369/0001209191-18-063369-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063370/0001209191-18-063370-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063372/0001209191-18-063372-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063373/0001209191-18-063373-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063795/0001209191-18-063795-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063801/0001209191-18-063801-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/0001209191-18-063802-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063803/0001209191-18-063803-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063804/0001209191-18-063804-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919118063805/0001209191-18-063805-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007485/0001209191-19-007485-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/0001209191-19-007486-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007487/0001209191-19-007487-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007488/0001209191-19-007488-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007489/0001209191-19-007489-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119007490/0001209191-19-007490-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015882/0001209191-19-015882-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015888/0001209191-19-015888-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015892/0001209191-19-015892-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015894/0001209191-19-015894-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119015898/0001209191-19-015898-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035829/0001209191-19-035829-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035830/0001209191-19-035830-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035832/0001209191-19-035832-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035835/0001209191-19-035835-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035840/0001209191-19-035840-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119035916/0001209191-19-035916-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041173/0001209191-19-041173-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041174/0001209191-19-041174-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119041175/0001209191-19-041175-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119054623/0001209191-19-054623-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061067/0001209191-19-061067-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061068/0001209191-19-061068-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061069/0001209191-19-061069-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061536/0001209191-19-061536-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061540/0001209191-19-061540-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919119061545/0001209191-19-061545-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120002761/0001209191-20-002761-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120002767/0001209191-20-002767-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006666/0001209191-20-006666-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006667/0001209191-20-006667-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120006668/0001209191-20-006668-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016065/0001209191-20-016065-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016073/0001209191-20-016073-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016076/0001209191-20-016076-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016078/0001209191-20-016078-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016081/0001209191-20-016081-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016084/0001209191-20-016084-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016086/0001209191-20-016086-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016088/0001209191-20-016088-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016090/0001209191-20-016090-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016092/0001209191-20-016092-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034060/0001209191-20-034060-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034065/0001209191-20-034065-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034068/0001209191-20-034068-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120034076/0001209191-20-034076-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035025/0001209191-20-035025-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035029/0001209191-20-035029-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035031/0001209191-20-035031-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035032/0001209191-20-035032-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035033/0001209191-20-035033-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035034/0001209191-20-035034-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035056/0001209191-20-035056-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120035059/0001209191-20-035059-index.htm
2020-07-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120041565/0001209191-20-041565-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000120919120049398/0001209191-20-049398-index.htm
2020-04-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1557746/000123191920000022/0001231919-20-000022-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837018009771/0001558370-18-009771-index.htm
2019-01-188-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019000179/0001558370-19-000179-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019000521/0001558370-19-000521-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002208/0001558370-19-002208-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1557746/000155837019002211/0001558370-19-002211-index.htm
2019-03-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002649/0001558370-19-002649-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019002790/0001558370-19-002790-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1557746/000155837019003262/0001558370-19-003262-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1557746/000155837019003265/0001558370-19-003265-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019004465/0001558370-19-004465-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019004494/0001558370-19-004494-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005495/0001558370-19-005495-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005542/0001558370-19-005542-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019005736/0001558370-19-005736-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019006015/0001558370-19-006015-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019006557/0001558370-19-006557-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019007711/0001558370-19-007711-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019007745/0001558370-19-007745-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008497/0001558370-19-008497-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008709/0001558370-19-008709-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008878/0001558370-19-008878-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019008933/0001558370-19-008933-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019010383/0001558370-19-010383-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837019010425/0001558370-19-010425-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019011167/0001558370-19-011167-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837019011272/0001558370-19-011272-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020000075/0001558370-20-000075-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020000132/0001558370-20-000132-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020001319/0001558370-20-001319-index.htm
2020-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1557746/000155837020001325/0001558370-20-001325-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020003444/0001558370-20-003444-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1557746/000155837020004176/0001558370-20-004176-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1557746/000155837020004178/0001558370-20-004178-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020005715/0001558370-20-005715-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020005744/0001558370-20-005744-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1557746/000155837020005771/0001558370-20-005771-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020006658/0001558370-20-006658-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020006989/0001558370-20-006989-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007276/0001558370-20-007276-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007565/0001558370-20-007565-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020007743/0001558370-20-007743-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020009808/0001558370-20-009808-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020009814/0001558370-20-009814-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020010689/0001558370-20-010689-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020011154/0001558370-20-011154-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1557746/000155837020012486/0001558370-20-012486-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1557746/000155837020012488/0001558370-20-012488-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1557746/000161577419002509/0001615774-19-002509-index.htm
2020-04-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1557746/999999999520000907/9999999995-20-000907-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1557746/999999999718009613/9999999997-18-009613-index.htm
2019-05-09CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1557746/999999999719004164/9999999997-19-004164-index.htm

Aclaris Therapeutics, Inc (ACRS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aclaris Therapeutics, Inc (ACRS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 964%
Institutional Ownership: 6613%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02Neal WalkerPresident and CEOBuy96,150.001,025,053.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-03-02Kamil Ali-JacksonChief Legal OfficerBuy17,175.00103,978.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016073/0001209191-20-016073-index.htm
2020-03-02Neal WalkerPresident and CEOBuy52,564.001,049,994.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016095/0001209191-20-016095-index.htm
2020-06-01David N. GordonChief Medical OfficerBuy87,500.00106,940.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034065/0001209191-20-034065-index.htm
2019-06-26James E Flynn10% Share HolderSell352.004.501,584.531,072,775.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-06-25James E Flynn10% Share HolderSell10,634.004.5147,947.641,073,127.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-24James E Flynn10% Share HolderSell13,063.004.5259,077.421,083,761.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-21James E Flynn10% Share HolderSell70,135.004.62323,701.081,096,824.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2020-06-01Neal WalkerPresident and CEOBuy73,014.001,107,907.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034076/0001209191-20-034076-index.htm
2019-05-10James E Flynn10% Share HolderSell71,869.006.05434,749.951,166,959.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-09-01Neal WalkerPresident and CEOBuy83,092.001,170,023.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120049398/0001209191-20-049398-index.htm
2019-02-01Brett FairChief Commercial OfficerBuy3,875.0011,890.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/0001209191-19-007486-index.htm
2019-05-09James E Flynn10% Share HolderSell172,800.006.161,064,016.001,238,828.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-06-01Kamil Ali-JacksonChief Legal OfficerBuy33,188.00132,387.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034060/0001209191-20-034060-index.htm
2018-12-15Christopher PowalaChief Reg & Develop OfficerBuy1,300.00138,621.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063368/0001209191-18-063368-index.htm
2018-12-18Christopher PowalaChief Reg & Develop OfficerBuy1,625.00139,889.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063801/0001209191-18-063801-index.htm
2019-02-01Christopher PowalaChief Reg & Develop OfficerBuy3,400.00142,843.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007489/0001209191-19-007489-index.htm
2018-12-15Frank RuffoChief Financial OfficerBuy1,300.00161,885.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063372/0001209191-18-063372-index.htm
2020-06-06Anand MehraDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035033/0001209191-20-035033-index.htm
2020-06-06ANDREW N SCHIFFDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035029/0001209191-20-035029-index.htm
2020-06-06Bryan M. ReasonsDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035059/0001209191-20-035059-index.htm
2020-06-06William D. HumphriesDirectorBuy7,333.0016,209.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035032/0001209191-20-035032-index.htm
2018-12-18Frank RuffoChief Financial OfficerBuy1,250.00162,765.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063805/0001209191-18-063805-index.htm
2020-03-02Christopher P. MolineauxDirectorBuy8,876.0016,558.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016084/0001209191-20-016084-index.htm
2019-12-16Frank RuffoChief Financial OfficerBuy1,300.00166,276.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061068/0001209191-19-061068-index.htm
2019-02-01Frank RuffoChief Financial OfficerBuy3,875.00166,284.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007487/0001209191-19-007487-index.htm
2020-06-06Andrew Kenneth William PowellDirectorBuy7,333.0016,709.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035031/0001209191-20-035031-index.htm
2019-12-18Frank RuffoChief Financial OfficerBuy1,250.00167,156.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061540/0001209191-19-061540-index.htm
2020-02-03Frank RuffoChief Financial OfficerBuy3,875.00170,675.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006667/0001209191-20-006667-index.htm
2020-03-02Frank RuffoChief Financial OfficerBuy25,750.00195,117.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016092/0001209191-20-016092-index.htm
2020-06-01Frank RuffoChief Financial OfficerBuy33,188.00221,143.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120034068/0001209191-20-034068-index.htm
2020-06-06Christopher P. MolineauxDirectorBuy7,333.0023,891.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120035034/0001209191-20-035034-index.htm
2020-03-02David N. GordonChief Medical OfficerBuy20,600.0024,952.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016065/0001209191-20-016065-index.htm
2018-12-15Stuart ShanlerChief Scientific OfficerBuy1,300.00268,812.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063370/0001209191-18-063370-index.htm
2018-12-18Stuart ShanlerChief Scientific OfficerBuy1,450.00269,892.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063803/0001209191-18-063803-index.htm
2019-02-01Stuart ShanlerChief Scientific OfficerBuy3,875.00273,355.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007488/0001209191-19-007488-index.htm
2019-06-27James E Flynn10% Share HolderSell590,801.002.691,589,668.253,159,165.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm
2019-06-26James E Flynn10% Share HolderSell1,352.004.506,086.033,749,966.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000603/0001193805-19-000603-index.htm
2019-06-25James E Flynn10% Share HolderSell40,850.004.51184,188.573,751,318.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-24James E Flynn10% Share HolderSell50,177.004.52226,925.483,792,168.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-06-21James E Flynn10% Share HolderSell269,402.004.621,243,397.993,842,345.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000599/0001193805-19-000599-index.htm
2019-05-10James E Flynn10% Share HolderSell108,696.006.05657,523.844,111,747.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2019-05-09James E Flynn10% Share HolderSell261,345.006.161,609,231.844,220,443.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000485/0001193805-19-000485-index.htm
2020-03-02MAXINE GOWENDirectorBuy4,438.004,438.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016076/0001209191-20-016076-index.htm
2019-07-02David N. GordonChief Medical OfficerBuy6,000.006,000.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119041173/0001209191-19-041173-index.htm
2018-12-15Kamil Ali-JacksonChief Legal OfficerBuy1,733.0079,369.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063369/0001209191-18-063369-index.htm
2018-12-18Kamil Ali-JacksonChief Legal OfficerBuy1,075.0079,951.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063795/0001209191-18-063795-index.htm
2019-02-01Kamil Ali-JacksonChief Legal OfficerBuy3,875.0083,520.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007485/0001209191-19-007485-index.htm
2019-12-16Kamil Ali-JacksonChief Legal OfficerBuy1,733.0083,945.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061067/0001209191-19-061067-index.htm
2019-12-18Kamil Ali-JacksonChief Legal OfficerBuy1,075.0084,523.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061536/0001209191-19-061536-index.htm
2018-12-18Brett FairChief Commercial OfficerBuy1,750.008,513.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/0001209191-18-063802-index.htm
2020-02-03Kamil Ali-JacksonChief Legal OfficerBuy3,875.0088,121.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006666/0001209191-20-006666-index.htm
2020-03-02Anand MehraDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016081/0001209191-20-016081-index.htm
2020-03-02ANDREW N SCHIFFDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016090/0001209191-20-016090-index.htm
2020-03-02Bryan M. ReasonsDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016088/0001209191-20-016088-index.htm
2020-03-02William D. HumphriesDirectorBuy8,876.008,876.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016078/0001209191-20-016078-index.htm
2020-07-02David N. GordonChief Medical OfficerBuy6,000.0088,895.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120041565/0001209191-20-041565-index.htm
2018-12-15Neal WalkerPresident and CEOBuy3,033.00908,895.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063373/0001209191-18-063373-index.htm
2018-12-18Neal WalkerPresident and CEOBuy2,925.00910,957.00https://www.sec.gov/Archives/edgar/data/1557746/000120919118063804/0001209191-18-063804-index.htm
2019-12-16Neal WalkerPresident and CEOBuy3,033.00920,378.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061069/0001209191-19-061069-index.htm
2019-02-01Neal WalkerPresident and CEOBuy10,800.00920,924.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119007490/0001209191-19-007490-index.htm
2019-12-18Neal WalkerPresident and CEOBuy2,925.00922,521.00https://www.sec.gov/Archives/edgar/data/1557746/000120919119061545/0001209191-19-061545-index.htm
2020-02-03Neal WalkerPresident and CEOBuy10,800.00932,578.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120006668/0001209191-20-006668-index.htm
2020-03-02Andrew Kenneth William PowellDirectorBuy8,876.009,376.00https://www.sec.gov/Archives/edgar/data/1557746/000120919120016086/0001209191-20-016086-index.htm
2019-06-27James E Flynn10% Share HolderSell108,674.002.69292,409.13964,101.00https://www.sec.gov/Archives/edgar/data/1557746/000119380519000616/0001193805-19-000616-index.htm